| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Interleukin-6|IL-6|B-cell stimulatory factor 2|BSF-2|CTL differentiation factor|CDF|Hybridoma growth factor|Interferon beta-2|IFN-beta-2|IL6|IFNB2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human IL-6 (Interleukin 6) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Cytokines are secreted signaling proteins that coordinate immune responses and inflammation through receptor-mediated pathways.
Biological role and mechanism
The biological role of IL-6 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of IL-6 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
IL-6 (Interleukin 6) may also be referenced as Interleukin-6, IL-6, and B-cell stimulatory factor 2 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how IL-6 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in IL-6 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
IL-6 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Clinical and Pathophysiological Characteristics of Non-acute Decompensation of Cirrhosis
IF: 26.8 Journal: Journal of Hepatology Author: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India. Cited Date: 2025-03-14
A multirisk-rescued biomimetic nanozyme against periodontitis via inflammation targeting and microenvironment reprogramming
IF: 13.4 Journal: Chemical Engineering Journal Author: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Diseases, Department of Periodontology, School of Stomatology, The Four Cited Date: 2025-03-07
5-HT is associated with the dysfunction of regulating T cells in patients with allergic rhinitis
IF: 10.19 Journal: Clinical Immunology Cited Date: 2022-11-25
Ceria‐Nanoparticle‐Entangled Reticulation for Angiogenic and Therapeutic Embrocation for Multifactorial Approach to Treat Diabetic Wound
IF: 10 Journal: Advanced Healthcare Materials Author: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, 08826, Republic of Korea. Cited Date: 2025-04-11
Distance-Based All-In-One Immunodevice for Point-of-Care Monitoring of Cytokine Interleukin-6
IF: 9.618 Journal: ACS Sensors Cited Date: 2022-10-14
AGE induced macrophage-derived exosomes induce endothelial dysfunction in diabetes via miR-22-5p/FOXP1
IF: 8.5 Journal: Cardiovascular Diabetology Author: The Second Afliated Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, China. Cited Date: 2025-05-16
Bruceine A ameliorates ulcerative colitis via macrophage polarization: Targeting HSP90-mediated IL-17 signaling and NF-κB activation
IF: 8.3 Journal: Phytomedicine Author: Shenzhen Bao'an Authentic TCM Therapy Hospital, Shenzhen 518101, PR China. Cited Date: 2025-10-17
COMPARATIVE EVALUATION OF POVIDONE IODINE AND ALOE VERA ON GINGIVAL HEALTH: A RANDOMIZED CONTROLLED TRIAL
IF: 8.084 Journal: World Journal of Pharmaceutical Research Cited Date: 2020-06-18